Past World Bronchiectasis Day Campaigns

2024

Now in its third year, World Bronchiectasis Day 2024 continued to expand its global reach and increased awareness of bronchiectasis. This year’s theme focused on the importance of research and how people can participate in research and clinical trials. The Global Planning Committee, led by Tim Aksamit, M.D., Medical Director of Bronchiectasis and NTM 360 at the COPD Foundation, and Professor James Chalmers, MBChB, Ph.D., EMBARC Chair and British Lung Foundation Chair of Respiratory Research, University of Dundee, helped organize several educational events and resources. In 2024, World Bronchiectasis Day reached 10.7 million people.

Read the 2024 World Bronchiectasis Day Impact Report, click here.

2023

Building off the momentum created from the previous year, the 2023 World Bronchiectasis Day campaign proved to be even more successful than its inaugural year. The theme for 2023 focused on treatment options and disease management goals. An international planning committee co-chaired by Dr. Tim Aksamit, Medical Director of Bronchiectasis and NTM 360 at the COPD Foundation and Pulmonary and Critical Care Specialist at Mayo Clinic, and Professor James Chalmers, EMBARC Chair and British Lung Foundation Chair of Respiratory Research, University of Dundee helped to organize the event. Multiple educational and awareness events were convened as part of a global schedule of events held in honor of World Bronchiectasis Day. An impressive 2.26 million media impressions were counted as a measurement of the success and the scale of World Bronchiectasis Day's reach.

To read a thorough World Bronchiectasis Day report, click here.

2022

The 2022 inaugural year of World Bronchiectasis Day was an amazing success. It was organized by an international planning committee co-chaired by Dr. Tim Aksamit, Medical Director of Bronchiectasis and NTM 360 at the COPD Foundation and Pulmonary and Critical Care Specialist at Mayo Clinic, and Professor James Chalmers, EMBARC Chair and British Lung Foundation Chair of Respiratory Research, University of Dundee. The global planning committee was comprised of patient advocates, representatives from collaborating advocacy organizations and professional societies, and leading experts.